| 1.13 0 (0%) | 07-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.73  |
1-year : | 3.63 |
| Resists | First : | 2.34 |
Second : | 3.1 |
| Pivot price | 1.5 |
|||
| Supports | First : | 1.1 |
Second : | 0.91 |
| MAs | MA(5) : | 1.2 |
MA(20) : | 1.5 |
| MA(100) : | 2.43 |
MA(250) : | 18.9 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 0.6 |
D(3) : | 2 |
| RSI | RSI(14): 39.4 | |||
| 52-week | High : | 169.6 | Low : | 1.1 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ IVF ] has closed above bottom band by 24.9%. Bollinger Bands are 38.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.17 - 1.18 | 1.18 - 1.18 |
| Low: | 1.08 - 1.09 | 1.09 - 1.1 |
| Close: | 1.12 - 1.13 | 1.13 - 1.14 |
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
Mon, 29 Jun 2026
What's Going On With INVO Fertility Stock Monday? - Sahm
Fri, 26 Jun 2026
INVO Fertility Inc Actuals & Estimates (NASDAQ:IVF) - TradingView
Fri, 26 Jun 2026
IVF Stock Jumps As Traders Pile Into Volatile Move - StocksToTrade
Fri, 26 Jun 2026
Why INVO Fertility Stock Is Surging Friday Afternoon - INVO Fertility (NASDAQ:IVF) - Benzinga
Thu, 25 Jun 2026
INVO Fertility Acquires Remaining HRCFG Stake for $175,001 to Fully Control Alabama Clinic - TradingView
Mon, 22 Jun 2026
INVO Fertility (IVF) grows Q1 2026 revenue 23% while overhauling balance sheet - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 2 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 18.2 (%) |
| Shares Short | 760 (K) |
| Shares Short P.Month | 92 (K) |
| EPS | 248.91 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.9 |
| Profit Margin | -158.8 % |
| Operating Margin | -79 % |
| Return on Assets (ttm) | -13.9 % |
| Return on Equity (ttm) | -102.3 % |
| Qtrly Rev. Growth | 23.1 % |
| Gross Profit (p.s.) | 1.48 |
| Sales Per Share | 4.03 |
| EBITDA (p.s.) | -3.16 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0.12 |
| Price to Sales | 0.28 |
| Price to Cash Flow | -0.38 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|